We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$14.7B
AUM Growth
-$2.91B
Cap. Flow
-$2.63B
Cap. Flow %
-17.88%
Top 10 Hldgs %
6.52%
Holding
4,319
New
695
Increased
988
Reduced
1,077
Closed
1,450

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$66.2M
2
WFC icon
Wells Fargo
WFC
+$57M
3
SNOW icon
Snowflake
SNOW
+$53.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$52.1M
5
AVGO icon
Broadcom
AVGO
+$43.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$76.6M
2
ZTS icon
Zoetis
ZTS
+$67.5M
3
UBER icon
Uber
UBER
+$57.3M
4
MMM icon
3M
MMM
+$53.2M
5
NFLX icon
Netflix
NFLX
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Industrials 6.14%
3 Consumer Discretionary 5.41%
4 Financials 4.9%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAC icon
3976
TransAlta
TAC
$3.93B
-164,502
Closed -$1.06M
TAK icon
3977
Takeda Pharmaceutical
TAK
$55.7B
-68
Closed -$945
TALK icon
3978
Talkspace
TALK
$874M
-198,459
Closed -$708K
TAP icon
3979
Molson Coors Class B
TAP
$8.09B
-34
Closed -$1.97K
TARS icon
3980
Tarsus Pharmaceuticals
TARS
$2.84B
-37,853
Closed -$1.38M
TASK icon
3981
TaskUs
TASK
$669M
-70,710
Closed -$824K
TBBK icon
3982
The Bancorp
TBBK
$2.84B
-193,428
Closed -$6.47M
TBPH icon
3983
Theravance Biopharma
TBPH
$877M
-5,834
Closed -$52.3K
TCRX icon
3984
TScan Therapeutics
TCRX
$52M
-44,308
Closed -$352K
TD icon
3985
PUT
Toronto Dominion Bank
TD
$200B
-39,900
Closed -$2.41M
TDC icon
3986
Teradata
TDC
$2.55B
-65,602
Closed -$2.54M
TECH icon
3987
CALL
Bio-Techne
TECH
$11.3B
-9,100
Closed -$641K
TECH icon
3988
PUT
Bio-Techne
TECH
$11.3B
-8,500
Closed -$598K
TEF
3989
DELISTED
Telefonica
TEF
-10,994
Closed -$48.5K
TEL icon
3990
CALL
TE Connectivity
TEL
$62.6B
-3,100
Closed -$450K
TENB icon
3991
Tenable Holdings
TENB
$4.01B
-25,020
Closed -$1.24M
TERN
3992
DELISTED
Terns Pharmaceuticals
TERN
-327
Closed -$2.15K
TFC icon
3993
Truist Financial
TFC
$64B
-108,652
Closed -$4.1M
TFII icon
3994
TFI International
TFII
$11.5B
-685
Closed -$109K
TGNA
3995
DELISTED
TEGNA Inc
TGNA
-9,388
Closed -$140K
TGTX icon
3996
PUT
TG Therapeutics
TGTX
$7.62B
-23,000
Closed -$350K
TH icon
3997
Target Hospitality
TH
$1.64B
-22,362
Closed -$243K
THRM icon
3998
Gentherm
THRM
$1.27B
-29,498
Closed -$1.7M
TIGR
3999
UP Fintech Holding
TIGR
$861M
-111,528
Closed -$384K
TITN icon
4000
Titan Machinery
TITN
$445M
-56,671
Closed -$1.41M

Similar funds

Cubist Systematic Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, Cubist Systematic Strategies held 4,319 positions worth $14.7B, down 17% from $17.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Cubist Systematic Strategies withdrew a net $2.63B in Q2 2024, closing 1,450 positions and reducing 1,077 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $76.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in General Motors worth $68.2M.

  • Cubist Systematic Strategies's largest Q2 2024 buy was General Motors: 1,467,209 shares worth $68.2M.
  • Cubist Systematic Strategies added most to Thermo Fisher Scientific in Q2 2024, an estimated $52.1M increase.
  • Cubist Systematic Strategies's biggest Q2 2024 reduction was Uber, cutting an estimated $57.3M.
  • Cubist Systematic Strategies fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $76.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.5% of its $14.7B portfolio in Q2 2024.
  • Cubist Systematic Strategies opened 695 new positions and closed 1,450 in Q2 2024.
  • Cubist Systematic Strategies's portfolio value fell 17% quarter-over-quarter to $14.7B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.